| Aurobindo Pharma announced that the United States Food and Drug Administration (US FDA) inspected Unit-I, a formulation manufacturing
facility, of Eugia Pharma Specialities, a wholly owned subsidiary of the Company, situated at Kolthur Village, Shameerpet Mandal, Ranga Reddy, 500078, Telangana, from February 16 to February 27, 2026. The inspection had concluded with 4 observations.
FDA has now determined that the inspection classification of this facility is “official action indicated” (OAI). |